Priyanka et al. [131] and An et al. [132] have suggested that GB can improve insulin resistance and inflammation resulting from the increase in the secretion of adiponectin, reducing serine phosphorylation of IRS-1 receptors, reducing NFκB/JNK activation, and, consequently, reducing the release of inflammatory adipokines. Here, ADIPOQ is linked to Insulin resistance.